Headlands Technologies LLC Has $4.57 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Headlands Technologies LLC decreased its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 7.5% in the fourth quarter, Holdings Channel reports. The institutional investor owned 19,660 shares of the financial services provider’s stock after selling 1,583 shares during the quarter. Headlands Technologies LLC’s holdings in CME Group were worth $4,566,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. SJS Investment Consulting Inc. raised its holdings in shares of CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares in the last quarter. Dunhill Financial LLC grew its stake in CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares in the last quarter. New Age Alpha Advisors LLC increased its position in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners purchased a new stake in shares of CME Group during the 4th quarter worth about $32,000. Finally, Knuff & Co LLC acquired a new stake in shares of CME Group during the 4th quarter valued at about $33,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

CME opened at $265.29 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock’s 50 day moving average price is $250.30 and its two-hundred day moving average price is $236.21. The firm has a market capitalization of $95.60 billion, a P/E ratio of 27.43, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $267.91.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were given a dividend of $1.25 per share. The ex-dividend date was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.88%. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio is currently 51.71%.

CME Group declared that its Board of Directors has initiated a share buyback program on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on CME shares. Barclays increased their price objective on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Royal Bank of Canada increased their price target on shares of CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 13th. Morgan Stanley lifted their price objective on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Finally, Erste Group Bank upgraded CME Group to a “strong-buy” rating in a report on Monday, March 17th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $238.93.

Read Our Latest Research Report on CME Group

Insider Activity at CME Group

In related news, Director Howard J. Siegel sold 10,000 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the transaction, the director now directly owns 21,873 shares of the company’s stock, valued at $5,686,980. This trade represents a 31.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the sale, the chief operating officer now directly owns 8,036 shares in the company, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 27,076 shares of company stock worth $6,871,496. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.